Antihelminthics are a group of antiparasitic drugs that kill and expel parasitic worms & other internal parasites from the body without causing any significant damage to the patient. These drugs are used for the treatment of various diseases such as fasciolasis, filariasis, angiostrongylosis, and many others. Increasing prevalence of diseases such as schistosomiasis, whipworm infection, ascariasis, and other intestinal infections have boosted the growth of the antihelminthic drugs market. The Global Antihelminthics Market is expected to grow at a CAGR of ~5.3 % during the forecast period 2017-2023.
According to the World Health Organization (WHO) in 2014, over 1.5 billion people were infected with soil-transmitted helminthes worldwide. Additionally, a latest report published by the WHO says that more than 880 million children are in the need of treatment for these parasitic diseases. A number of different types of antiparasitic drugs are available in the market for the treatment of the different parasitic diseases. According to a research, ascariasis remains the most common intestinal parasite with 807–1221 million infections globally.
Antihelminthics is the most prevalent diseases in East Asia, sub-Saharan Africa, and India. Majority of the patients are in developing region due to unhygienic condition. Over 65% of the patient population suffering from parasitic diseases are present in East Asia, sub-Saharan Africa, and India. Moreover, increasing geriatric population, rapidly developing healthcare sector, and increasing demand for the treatment of the parasitic diseases have fuelled the market growth. On the other hand, the side effects associated with the treatment may slow the market growth over the review period.
Global Antihelminthics Market – Dominant Players
Some of key the players in the market are Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Johnson & Johnson Services, Inc (US), Sanofi (US), Merck & Co., Inc. (US), GlaxoSmithKline plc (US), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), and AstraZeneca (UK).
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4500 .
Global Antihelminthics Market – Segmentation
The Global Antihelminthics Market has been segmented on the basis of types, application, and end user.
On the basis of types, the market is segmented into benzimidazoles, abamectin, salicylanilides, praziquantel and others. Benzimidazoles is further segmented into albendazole, mebendazole, benzimidazoles, thiabendazole, and others. Salicylanilides is further segmented into niclosamide, oxyclozanide, rafoxanide, and others.
On the basis of applications, the market is segmented into schistosomiasis, fasciolasis, filariasis, angiostrongylosis, ascariasis, giardiasis and others.
On the basis of end user, the market is segmented into hospitals, clinics, and others.
Global Antihelminthics Market – Regional Analysis
The Americas command the major share of the market owing to the large patient population, strong government support for research & development, growing prevalence of digestive diseases. According to the National Institute of Diabetes and Digestive and Kidney Diseases, over 135 million people are suffering from GI infection in America. Moreover, increasing geriatric population has fuelled the growth of the market.
Europe holds the second position in the global antihelminthics market followed by Asia Pacific. The growth of the European market is majorly attributed to the increasing geriatric population, government support, and well-developed healthcare sector. Asia Pacific is the fastest growing antihelminthics market. China, and India are the key contributors to the market growth due to huge patient population, rapidly growing economy to support the population, increasing healthcare expenditure, and huge population base.
The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition in African region. However the growth of the Africa market is high due to presence of opportunities for the development of this market.
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4500 .
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
List of Tables
Table 1 Antihelminthics Industry Synopsis, 2017 – 2023
Table 2 Global Antihelminthics Market Estimates and Forecast, 2017 – 2023, (USD Million)
Table 3 Global Antihelminthics Market by Region, 2017 – 2023, (USD Million)
Table 4 Global Antihelminthics Market by Types, 2017 – 2023, (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Segmentation for Global Antihelminthics Market
Figure 3 Segmentation Market Dynamics for Global Antihelminthics Market
Figure 4 Global Antihelminthics Market Share, By Type 2016
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar